(Q44662300)

5 December 2017

0 references

Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats (English)

1 reference

5 December 2017

1 reference

3

1 reference

5 December 2017

6

Jennifer L Cornish

1 reference

5 December 2017

Murray R Thompson

1

1 reference

5 December 2017

Kong M Li

2

1 reference

5 December 2017

Clint G Gurtman

4

1 reference

5 December 2017

Glenn E Hunt

5

1 reference

5 December 2017

Iain S McGregor

7

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

5 December 2017

published in

Neuropsychopharmacology

1 reference

5 December 2017

volume

29

1 reference

5 December 2017

issue

4

1 reference

5 December 2017

page(s)

694-704

1 reference

Behavioral, neuroendocrine and serotonergic consequences of single social defeat and repeated fluoxetine pretreatment in the Lewis rat strain.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: a comparison with fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

The lowest effective dose of fluoxetine in the forced swim test significantly affects the firing rate of lateral septal nucleus neurones in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Assessing antidepressant activity in rodents: recent developments and future needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Can social interaction be used to measure anxiety?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Chronic fluoxetine in tests of anxiety in rat lines selectively bred for differential 5-HT1A receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotoninergic inhibition of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Behavioral effects of acute and chronic fluoxetine in Wistar-Kyoto rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Further evidence for the predictive validity of the unstable elevated exposed plus-maze, a behavioural model of extreme anxiety in rats: differential effects of fluoxetine and chlordiazepoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Long term psychiatric and cognitive effects of MDMA use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Individual differences in vulnerability to inescapable shock in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Ecstasy (MDMA): a review of its possible persistent psychological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

The emergence test: effects of psychotropic drugs on neophobic disposition in Wistar Kyoto (WKY) and Sprague Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Behavioural despair in rats: A new model sensitive to antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Conditioned taste aversion induced by fluoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Synergistic action of p-chloroamphetamine and fluoxetine on food and water consumption patterns in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Strain-dependent modification of behavior following antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Effects of acute and chronic fluoxetine treatment of CRH-induced anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Cognitive performance and serotonergic function in users of ecstasy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Working memory deficits in current and previous users of MDMA ('ecstasy').

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

7 January 2021

MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

7 January 2021

Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

7 January 2021

Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

7 January 2021

Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

7 January 2021

Regulation of high- and low-affinity [3H]imipramine recognition sites in rat brain by chronic treatment with antidepressants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

7 January 2021

Anxiolytic-like effect of paroxetine in a rat social interaction test

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

7 January 2021

Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

7 January 2021

Influence of fluoxetine on regional serotonin synthesis in the rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

7 January 2021

Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

7 January 2021

Ecstasy use in Australia: patterns of use and associated harm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300347

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300347

1 reference

Dimensions Publication ID

5 December 2017

1007733178

0 references

1 reference